Abstract PS1-10-05: Efficacy and Safety of PI3K Inhibitors in Hormone Receptor Positive, HER 2 Negative Advanced Breast Cancer: A Meta-Analysis of Phase III Randomized Controlled Trials
2026 · Clinical Cancer Research · 0 citations
https://doi.org/10.1158/1557-3265.sabcs25-ps1-10-05